Research
Huntington Initiates National Health Investors at Outperform With $79 Price Target
National Health Investors (NHI) has an average rating of overweight and mean price target of $81.56, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
$NHI
